Ralinepag XR is under clinical development by United Therapeutics and currently in Phase III for Pulmonary Arterial Hypertension.

Increasing average concentrations of sotatercept improved 6-minute walk distance, pulmonary vascular resistance, and levels of NT-proBNP.

Treprostinil is under clinical development by United Therapeutics and currently in Phase III for Idiopathic Pulmonary Fibrosis.

INR:6834. ronaldinho age Wuhan will negotiate prices for 30 key monitored drugs, with companies' quotations to drop by at least 30% Zhengda Tianqing's first generi ...

INR:4330. 2019 cricket world cup Zhengda Tianqing's first generic version of pulmonary arterial hypertension drug "Macitentan Tablets" is about to be appro ...

how do i login to bet365 Fosun Pharma's Phase I clinical trial of novel coronavirus mRNA vaccine approved Domestic drugs are rising in the pulmonary arterial hypertension market, and original research ...

INR:8451. portugal league table Jiyao Holdings was fined RMB 1.3 million by the China Securities Regulatory Commission for suspected illegal information dis ...

INR:4979. kalyan final number today Bristol-Myers Squibb's Abatacept Injection is approved for marketing by the National Medical Products Administration ...

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year.

INR:6967. unibet recension National public hospital survey begins! Zhengda Tianqing's first generic version of pulmonary arterial hypertension drug "Macitentan T ...

Johnson & Johnson (NYSE:JNJ – Get Free Report)’s stock price was down 1.4% during mid-day trading on Monday . The company traded as low as $143.05 and last traded at $143.08. Approximately 1,041,140 ...